NSE: FDC | BSE: 531599

Mid-range Performer

Download real time

421.65 -25.55 (-5.71%)

929.3K NSE+BSE Volume

High volume+loss today

NSE 06 Nov, 2025 3:31 PM (IST)

6,864.9

Market Cap

Above industry Median

0.7

Beta 1Year

Very Low volatility

Board Meeting

The latest board meeting for FDC Ltd. took place on 05 Nov 2025, for the purpose of Quarterly Results & Others See details

FDC Ltd. share price target and research reports

Name: Latest research reports of FDC Ltd. authored by Rudra Shares and Stock Brokers Ltd and published by - Trendlyne research reports.
Item: FDC Ltd.
Rating: 5
Author: Rudra Shares and Stock Brokers Ltd

Latest analyst research reports with target prices and PDF download for FDC, BSE:531599 FDC Ltd.

Search Inside the pdf :

FDC Ltd.

11 Nov 2019

421.65

-5.71%

FDC Ltd

Buy: FDC Ltd.

Rudra Shares and Stock Brokers Ltd

Forerunner in manufacturing and marketing of Oral Rehydration Salts (ORS) and Ophthalmic & First in South East Asia to offer ophthalmic formulations, using Blow-Fill-Seal (BFS) technology. FDC is a fundamentally strong company with huge cash in its balance sheet. The company has good product profile starting with Electral which is the market leader in the ORS segment. Moreover, company continues to report decent operating margins and generates sufficient free cash flow from operations every year where part has been used for buyback in the past, for...

FDC Ltd. is trading at high volume of 802.2K with price loss of -5.71.

FDC Ltd.

07 Aug 2018, 12:00AM

421.65

-5.71%

FDC Ltd

Buy: FDC Ltd.

ICICI Securities Limited

FDC Ltd. is trading at high volume of 802.2K with price loss of -5.71.

FDC Ltd.

21 Aug 2017

421.65

-5.71%

FDC Ltd.

Buy: FDC Ltd.

Choice India

FDC Limited (Food, Drugs and Chemicals) is a fully integrated pharmaceutical company which has been in business for more than 70 years. The company is engaged in manufacturing of specialized formulations and oral rehydration salts (ORS) since 1972. The company is currently ranked 26th in India as per AWACS-AIOCD, recording a growth of 3.7% and attaining a market share of 0.89% whereas IPM (Indian Pharmaceutical markets) recorded a growth of 10.3% as per secondary sales, as of March 2017. The Company has built a visible presence across markets in Europe, USA, Asia, Africa, Latin America and Confederation of Independent States (CIS). It has...

FDC Ltd. average weekly volume is high.

FDC Ltd.

05 Dec 2016, 08:39AM

421.65

-5.71%

Pick of the week - FDC Ltd

Buy: FDC Ltd.

HDFC Securities

BUY FDC Ltd between Rs. 192 - 218, for the Target Price of Rs. 255 - 290

FDC Ltd. average weekly volume is high.

FDC Ltd.

31 Dec 2013

421.65

-5.71%

FDC Limited

Buy: FDC Ltd.

Ashika Research

bulk drugs. The therapeutic segment consists of products such formulations, antioxidants and haematinics. But FDC is best known for its oral re-hydration salts (ORS) sold under the brand...

FDC Ltd. average weekly volume is high.

Is FDC Ltd. worth buying?

137 Votes:

Buy 80.29%

Sell 8.03%

Hold 11.68%